I truly want Generex / NGIO to succeed as viable companies,

New Post Public Reply Private Reply Replies (0) Message Board
hylander
739
I truly want Generex / NGIO to succeed as viable companies, for shareholders and for people that they can help by their products. All shareholders should want that for any company that they invest in. That's just common sense.

However, as a shareholder, I also expect certain things from a company as well. Since I have invested in said company, expectations are that the company deliver on timetables they have set. The company provide timely updates on statements that they have made in the past. The company conduct themselves in a manner that is professional and shows confidence in what they are doing.

In the past, the only thing I have seen from the management is that they have shown confidence in what they are doing. On calls or in interviews, I have seen or heard them sound very confident and at times professional. However, that is where it ends.

The timely updates are non existent, the timetables have been missed repeatedly, statements have been inaccurate multiple times. These are all facts that cannot even be debated.

We are at a point where the stock is close to a 52 week low. We have been waiting for updates on several items - IND, IPO, Excellegan, Clinics, New Deals they discussed, China.

Multiple items that need to be addressed that have been waiting for months now. We will soon be ending August, the 8th month of 2021. Goals that were supposed to be met by now, have not. Bad actors have come and gone, Covid is here and will be here and businesses have adjusted, states have opened up accordingly, I know for a fact the medical field of teleconferencing is thriving for doctor / patients. and we still have not heard from the management what is going on with anything.

No updates, no CC, no PR, no Web update,

I know this sounds like a broken record, but this company needs to do better, much better if it hopes to compete in a world of a million other companies with products similar but with better marketing, better communication, better management who care about their shareholders and value the people who support them.

Joe said so often he took care of his shareholders more than any other CEO. Where is that care now? Other companies will pass Generex / NGIO by because they have the total package in a world that values communication.

I hope Generex / NGIO listens before it is to late.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Comcast Unveils Game-Changing Next-Gen Video AI

Updated Category News Views 2

Comcast Technology Solutions Takes a Big Swing Well, Comcast Technology Solutions (CTS) is stepping up to the plate with an offering that just might knock it out of the park for broadcasters and content creators. They're rolling out an ambitious suite of AI-powered video workflow tools that could potentially redefine how operators handle their media libraries. The buzz is...

Continue Reading
California's Annual Recovery Happens Event Unites Community

Updated Category News Views 1

A Public Campaign for Recovery Awareness Anyone with a pulse on what's going on in the addiction recovery landscape knows the significance of events like Recovery Happens. It's not just another day in Sacramento; it's a rallying cry for change—a public affirmation that recovery is tangible and thriving. This isn't about showy gala dinners or fancy corporate events; it's...

Continue Reading
D-Orbit Banks on GomSpace for 2026 Space Ventures

Updated Category News Views 4

Pioneering Paths in Space Logistics Nobody ever said that conquering the final frontier was going to be easy. But D-Orbit, the trailblazer in space logistics, is inking deals like they're playing a cosmic chess game, and GomSpace is the knight they’re moving across the board. Their latest maneuver? GomSpace gets tasked with powering the D-Orbit's missions through 2027,...

Continue Reading
TDS Kills Array Merger, Revives Stock Buyback Plans

Updated Category News Views 2

Shifting Gears: TDS Drops Array Deal There's always something brewing in the halls of corporate mergers. Just when you thought Telephone and Data Systems, Inc. (TDS) was about to cinch a deal with Array Digital Infrastructure, Inc. (NYSE: AD), they've turned the car around. TDS decided it won't be going ahead with its acquisition of the remaining shares it doesn't already...

Continue Reading
Wix Faces Class Action: What's at Stake?

Updated Category News Views 3

Wix's Latest Woes: More Than Just Growing Pains In the rough-and-tumble world of tech stocks, Wix.com Ltd. (NASDAQ: WIX) is taking quite a hit where it hurts—right in the valuation. On the heels of a bruising 27% drop in share price after disclosing its Q1 2026 numbers, they've got a securities class action breathing down their necks. We're talking ticket number Yappi...

Continue Reading
Moab Launches Free Shuttle to Enhance Park Access

Updated Category News Views 2

Moab's Shuttle: A New Era for Park Access A breeze of change is sweeping through the dusty trails of Moab, Utah, and this isn't just any switch—it's about making the always-packed Arches National Park a bit less of a traffic nightmare. Imagine this: strolling up to a shuttle, no tickets, no cash needed, and you're off to see epic scenery like The Windows and Delicate...

Continue Reading
CIGRE 2026: Power Grids Crucial for Electrification Era

Updated Category News Views 0

Electrifying Ambitions at CIGRE 2026 Electricity isn't just flickering a light in a room anymore; it's the heartbeat of modern society. And folks, everyone’s talking about the CIGRE 2026 Paris Session where the big wigs of the power grid universe gathered. With over 15,000 experts and 330 exhibitors from a slew of countries, the spotlight was on building the grid of...

Continue Reading
Zepp Health's Q2 2026 Results: Growth Amid Struggles

Updated Category News Views 1

Revenue Growth, Yet the Road Is Rocky Buckle up, investors, because Zepp Health Corporation's (NYSE: ZEPP) latest financials are a bit of a mixed salad—there's some good and some bad tossed in. Reporting a revenue of $63.5 million for the second quarter of 2026, the company managed to eke out a 6.9% increase year-over-year. But before you pop the champagne, let's dig a...

Continue Reading
BC Mosaic App Store Unlocks New Tools for Researchers

Updated Category News Views 1

Unleashing Innovation Through Specialized Apps Oh boy, it's about time someone shook things up in the research game. BC Platforms has rolled out the BC Mosaic App Store, a move that's got research types buzzing from Zurich to... well, anywhere healthcare pokes its head. These guys aren't just throwing out some generic, run-of-the-mill tools. No sir, they've created a...

Continue Reading
Nexio's New Campus Ignites Truck Production Ambitions

Updated Category News Views 4

Big Moves into the Big Truck Arena Nexio Power is making significant strides in making heavy trucks powered by propane a reality. By securing a massive 77-acre campus in Anderson, Texas, the company is setting the stage for immediate production capabilities. It's not often you see a company like Nexio pulling the rug out from others so quietly but effectively. This campus...

Continue Reading

Top 5 Most Recently Viewed Articles

RentGuarantor Holdings PLC: Strategic Growth Initiatives Ahead

Updated Category News Views 118

RentGuarantor Holdings PLC’s Promising Growth and Future Plans RentGuarantor Holdings PLC (AQSE: RGG) has recently shared its exciting and optimistic outlook for the future, showcasing strong growth and strategic maneuvers aimed at expanding its market presence. The latest report reveals a notable 62% surge in revenue year-on-year for the third quarter of 2024,...

Continue Reading
VivoPower to Spin Off Caret Digital with $308 Million Valuation

Updated Category News Views 387

VivoPower Plans an Exciting Spin-Off of Caret Digital VivoPower International PLC (NASDAQ: VVPR) has announced major plans to spin off its subsidiary, Caret Digital, through a direct IPO on NASDAQ. This transaction is aimed at establishing Caret with a target market value of around US$308 million. The spin-off signifies a significant step in VivoPower's strategy to focus...

Continue Reading
Navigate Capricor Therapeutics Class Action with Expert Help

Updated Category News Views 104

Overview of Capricor Therapeutics Class Action Capricor Therapeutics, Inc. (NASDAQ: CAPR) has become the focus of a recent class action aimed at defending the interests of its shareholders. This initiative, led by The Gross Law Firm, addresses significant challenges faced by investors over the past year. What is the Class Action About? This class action relates to...

Continue Reading
Navigating Career Opportunities Amid Layoffs and Hiring Freezes

Updated Category News Views 209

Finding Stability in Uncertain Times As layoffs continue to affect various sectors, certain career paths are thriving and show promising growth potential. Surprisingly, many of these fields are accessible to newcomers. High Demand in Healthcare and Technical Fields Healthcare professions remain in high demand. Nurses, occupational therapists, and paramedics reported...

Continue Reading
Dr. Neal Blitz Leads Innovative Discussion on Minimally Invasive Surgery

Updated Category News Views 589

Revolutionizing Foot and Ankle Surgery Voom Medical Devices, Inc. is at the forefront of transforming the landscape of foot and ankle surgery through its commitment to minimally invasive techniques. The company is thrilled to announce that its Founder and CEO, Dr. Neal Blitz, DPM, FACFAS, has been appointed as the Guest Editor for the upcoming issue of Clinics in...

Continue Reading